Publications by authors named "M Dauriz"

Claim this Profile
E
Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2).
Maria E Malighetti, Fabio Vescini, Maria Carpentieri, Anna Altomari, Federica Turchi, Marco Dauriz

Minerva Endocrinol (Torino)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus in stroke unit: prevalence and outcomes-the Verona acute coronary syndrome and stroke in diabetes outcome (VASD-OUTCOME) study.
Marco Dauriz, Alessandro Csermely, Lorenza Santi, Elena Tregnaghi, Alberto Grotto

Acta Diabetol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS.
P Moghetti, C Catellani, C Sartori, M Migazzi, F Cirillo, M Dauriz

J Endocrinol Invest· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and beta-cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10.
Enzo Bonora, Maddalena Trombetta, Marco Dauriz, Corinna Brangani, Vittorio Cacciatori

Diabetes Metab Res Rev· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths.
Rocky Strollo, Ernesto Maddaloni, Marco Dauriz, Claudio Pedone, Raffaella Buzzetti

Diabetes Res Clin Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis